Franz DN - Search Results

1

A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC).

Zöllner JP, Franz DN, Hertzberg C, Nabbout R, Rosenow F, Sauter M, Schubert-Bast S, Wiemer-Kruel A, Strzelczyk A. Zöllner JP, et al. Among authors: franz dn. Orphanet J Rare Dis. 2020 Jan 21;15(1):23. doi: 10.1186/s13023-019-1258-3. Orphanet J Rare Dis. 2020. PMID: 31964424 Free PMC article. Review.

2

Diagnosis and management of tuberous sclerosis complex.

Franz DN. Franz DN. Semin Pediatr Neurol. 1998 Dec;5(4):253-68. doi: 10.1016/s1071-9091(98)80004-1. Semin Pediatr Neurol. 1998. PMID: 9874853 Review.

3

Non-neurologic manifestations of tuberous sclerosis complex.

Franz DN. Franz DN. J Child Neurol. 2004 Sep;19(9):690-8. doi: 10.1177/08830738040190091001. J Child Neurol. 2004. PMID: 15563016 Review.

4

Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial.

Collins JJ, Tudor C, Leonard JM, Chuck G, Franz DN. Collins JJ, et al. Among authors: franz dn. J Child Neurol. 2006 Jan;21(1):53-7. doi: 10.1177/08830738060210011201. J Child Neurol. 2006. PMID: 16551454

5

Current management of tuberous sclerosis complex.

Krueger DA, Franz DN. Krueger DA, et al. Among authors: franz dn. Paediatr Drugs. 2008;10(5):299-313. doi: 10.2165/00148581-200810050-00004. Paediatr Drugs. 2008. PMID: 18754697 Review.

6

Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.

Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, Wilson KA, Byars A, Sahmoud T, Franz DN. Krueger DA, et al. Among authors: franz dn. N Engl J Med. 2010 Nov 4;363(19):1801-11. doi: 10.1056/NEJMoa1001671. N Engl J Med. 2010. PMID: 21047224 Free article. Clinical Trial.

7

Psychiatric comorbidity and treatment response in patients with tuberous sclerosis complex.

Chung TK, Lynch ER, Fiser CJ, Nelson DA, Agricola K, Tudor C, Franz DN, Krueger DA. Chung TK, et al. Among authors: franz dn. Ann Clin Psychiatry. 2011 Nov;23(4):263-9. Ann Clin Psychiatry. 2011. PMID: 22073383

8

Everolimus alters white matter diffusion in tuberous sclerosis complex.

Tillema JM, Leach JL, Krueger DA, Franz DN. Tillema JM, et al. Among authors: franz dn. Neurology. 2012 Feb 21;78(8):526-31. doi: 10.1212/WNL.0b013e318247ca8d. Epub 2012 Jan 18. Neurology. 2012. PMID: 22262746 Clinical Trial.

9

Molecular therapies for tuberous sclerosis and neurofibromatosis.

Franz DN, Weiss BD. Franz DN, et al. Curr Neurol Neurosci Rep. 2012 Jun;12(3):294-301. doi: 10.1007/s11910-012-0269-4. Curr Neurol Neurosci Rep. 2012. PMID: 22544507 Review.

10

Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.

Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C, Mays M, Lopez CM, Kim MO, Franz DN. Krueger DA, et al. Among authors: franz dn. Ann Neurol. 2013 Nov;74(5):679-87. doi: 10.1002/ana.23960. Epub 2013 Sep 10. Ann Neurol. 2013. PMID: 23798472 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page